Tango Therapeutics, Inc. (TNGX) — Stock Price, Chart & Analysis
Tango Therapeutics, Inc. (TNGX) is a Healthcare stock currently trading at $27.07, down 6.66% on the day. It carries a market capitalization of $4.41B. Over the past 52 weeks, TNGX has traded between $6.25 and $34.39. Tango Therapeutics, Inc. does not currently pay a regular dividend. View the live TNGX chart, technical opinion, analyst ratings, fundamentals and latest news below.
Tango Therapeutics, Inc. (TNGX) key data
| Price | $27.07 |
| Change (today) | -6.66% |
| Previous close | $29 |
| Market cap | $4.41B |
| EPS (TTM) | $-0.77 |
| 52-week high | $34.39 |
| 52-week low | $6.25 |
| Beta | 1.15 |
| Avg. volume | 3.95M |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently asked questions about Tango Therapeutics, Inc. (TNGX)
How much does one share of Tango Therapeutics, Inc. cost?
As of the latest update, one share of Tango Therapeutics, Inc. (TNGX) trades at $27.07 (-6.66% today).
What is Tango Therapeutics, Inc.'s market cap?
Tango Therapeutics, Inc. has a market capitalization of approximately $4.41B.
What is Tango Therapeutics, Inc.'s earnings per share (EPS)?
Tango Therapeutics, Inc.'s trailing twelve-month EPS is $-0.77.
Does Tango Therapeutics, Inc. pay a dividend?
Tango Therapeutics, Inc. does not currently pay a regular dividend.
What is Tango Therapeutics, Inc.'s 52-week trading range?
Over the past year, TNGX has traded between $6.25 and $34.39.
What is the analyst price target for Tango Therapeutics, Inc.?
The mean analyst price target for Tango Therapeutics, Inc. is $44.33. This is informational only and not investment advice.
Latest Tango Therapeutics, Inc. (TNGX) news
- Tango Therapeutics Announces Executive Chair TransitionNews · Aug 6, 2026
- How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48%News · Jul 22, 2026
- Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined RevenuesNews · Jul 15, 2026
- 2 Monster Growth Stocks Analysts Think Can Reach New HighsNews · Jul 9, 2026
- Tango Therapeutics Rides a New Precision Oncology Trend in 2026News · Jul 2, 2026
- Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?News · Jul 2, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live TNGX dashboard…